E-LIB Suche - Ergebnisse für: Opstal, T S J

1

An Update on Inflammation in Atherosclerosis: How to Effect..:

Mohammadnia, N. ; Opstal, T.S.J. ; El Messaoudi, S...
Clinical Therapeutics. 45 (2023) 11 - p. 1055-1059 , 2023

Link: https://doi.org/10.1016/..

2

The effect of proprotein convertase subtilisin/kexin type 9..:

Kraaijenhof, J ; Cornel, J H ; Opstal, T S J...
European Heart Journal. 44 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

3

The effects of colchicine in patients with diabetes mellitu..:

Mohammadnia, N ; Los, J ; Opstal, T S J...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

4

End-of-trial inflammatory biomarkers, lipid levels, creatin..:

Van Broekhoven, A ; Mohammadnia, N ; Silvis, M J M...
European Heart Journal. 43 (2022) Supplement_2 - p. , 2022

Link: https://doi.org/10.1093/..

5

The effect of low-dose colchicine on cause-specific mortali..:

Opstal, T.S.J. ; Nidorf, S.M. ; Fiolet, A.T.L....
Atherosclerosis. 331 (2021) - p. e34-e35 , 2021

Link: https://doi.org/10.1016/..

6

Targeting residual inflammatory risk in coronary disease: t..:

Fiolet, A. T. L. ; Opstal, T. S. J. ; Silvis, M. J. M...
Netherlands Heart Journal. 30 (2021) 1 - p. 25-37 , 2021

Link: https://doi.org/10.1007/..

7

Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies At..:

Hoogeveen, R. ; Opstal, T.S.J. ; Kaiser, Y....
Atherosclerosis. 287 (2019) - p. e12 , 2019

Link: https://doi.org/10.1016/..

8

Targeting residual inflammatory risk in coronary disease: t..:

Fiolet, A. T. L ; Opstal, T. S. J ; Silvis, M. J. M..
Fiolet , A T L , Opstal , T S J , Silvis , M J M , Cornel , J H & Mosterd , A 2022 , ' Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail ' , Netherlands Heart Journal , vol. 30 , no. 1 , pp. 25-37 . https://doi.org/10.1007/s12471-021-01605-3. , 2022

Link: https://research.vumc.nl..

9

Targeting residual inflammatory risk in coronary disease: t..:

Fiolet, A. T. L ; Opstal, T. S. J ; Silvis, M. J. M..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724334/. , 2021

Link: http://www.ncbi.nlm.nih...

10

Drivers of mortality in patients with chronic coronary dise..:

Opstal, Tjerk S.J. ; Nidorf, Stefan M. ; Fiolet, Aernoud T.L....
International Journal of Cardiology. 372 (2023) - p. 1-5 , 2023

Link: https://doi.org/10.1016/..

11

Colchicine and diabetes in patients with chronic coronary a..:

Mohammadnia, Niekbachsh ; Los, Jan ; Opstal, Tjerk S. J....
Frontiers in Cardiovascular Medicine. 10 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

12

The Effect of Years-Long Exposure to Low-Dose Colchicine on..:

van Broekhoven, Amber ; Mohammadnia, Niekbachsh ; Silvis, Max J. M....
Clinical Drug Investigation. 42 (2022) 11 - p. 977-985 , 2022

Link: https://doi.org/10.1007/..

13

Letter to the editor: Colchicine and risk ofnon-cardiovascu..:

Fiolet, Aernoud T L ; Opstal, Tjerk S J ; Mosterd, Arend...
European Heart Journal - Cardiovascular Pharmacotherapy. 7 (2021) 4 - p. e71-e71 , 2021

Link: https://doi.org/10.1093/..

14

Efficacy and safety of low-dose colchicine in patients with..:

Fiolet, Aernoud T L ; Opstal, Tjerk S J ; Mosterd, Arend...
European Heart Journal. 42 (2021) 28 - p. 2765-2775 , 2021

Link: https://doi.org/10.1093/..

15

Colchicine reduces extracellular vesicle NLRP3 inflammasome..:

Silvis, Max J.M. ; Fiolet, Aernoud T.L. ; Opstal, Tjerk S.J....
Atherosclerosis. 334 (2021) - p. 93-100 , 2021

Link: https://doi.org/10.1016/..